Fiera Capital (Europe)’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-4,691
Closed -$279K 38
2015
Q4
$279K Hold
4,691
0.33% 27
2015
Q3
$255K Buy
4,691
+694
+17% +$45.2K 0.34% 23
2015
Q2
$269K Buy
+3,997
New +$261K 0.24% 24
2015
Q1
Sell
-5,332
Closed -$349 49
2014
Q4
$349 Hold
5,332
0.26% 24
2014
Q3
$309K Hold
5,332
0.22% 28
2014
Q2
$301K Buy
5,332
+1,368
+35% +$71.8K 0.24% 23
2014
Q1
$204K Buy
3,964
+201
+5% +$10.2K 0.15% 25
2013
Q4
$199K Buy
+3,763
New +$185K 0.11% 26

Other funds holding ABBV

Fiera Capital (Europe)'s ABBV Position: Q1 2016 in Review

Fiera Capital (Europe) sold out of AbbVie (ABBV) in Q1 2016, closing a stake of 4,691 shares — an estimated $279K sold.

Fiera Capital (Europe) first reported a position in ABBV in Q4 2013 and held it in 8 quarters. The position peaked at $309K in Q3 2014. 1,638 funds tracked by Wall St. Rank hold ABBV as of Q1 2016.

  • Fiera Capital (Europe) reported no remaining AbbVie position as of Q1 2016 after selling out during the quarter.
  • Fiera Capital (Europe) sold 4,691 AbbVie shares in Q1 2016, an estimated $279K.
  • Fiera Capital (Europe) first reported a position in AbbVie in Q4 2013 and held it in 8 quarters.
  • Fiera Capital (Europe)'s AbbVie position peaked at $309K in Q3 2014.
  • 1,638 funds tracked by Wall St. Rank held AbbVie as of Q1 2016.

Based on Fiera Capital (Europe)'s 13F filing for Q1 2016, filed 5 May 2016.